Skip to main content
. 2017 Jun 15;61(1):18–24. doi: 10.3164/jcbn.16-114

Fig. 1.

Fig. 1

Treatment with astaxanthin C-8 (Ax-C-8) maintained renal function and antioxidant enzyme levels after ferric nitrilotriacetate (Fe-NTA)-induced oxidative injury. (A) Serum creatinine: Fe-NTA 4 h and 24 h, (B) serum BUN: Fe-NTA 4 h and 24 h. Protective effects of Ax-C-8 were observed, especially in the Fe-NTA 24 h group. (C) GSH peroxidase, (D) GSH reducase, (E) catalase. Attenuation of Fe-NTA-induced renal oxidative damage was observed in the Ax-C-8-treated group (ANOVA, p<0.0001, for a–e; #p<0.05 vs vehicle; *p<0.05; **p<0.01 vs vehicle + Fe-NTA and ***p<0.001 vs vehicle + Fe-NTA).